(Q53515076)
Statements
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. (English)
1 reference
1 reference
D L Fairclough
1 reference
B A Murphy
1 reference
J Bacik
1 reference
L H Schwartz
1 reference
D M Nanus
1 reference
T Mariani
1 reference
P Loehrer
1 reference
G Wilding
1 reference
D Cella
1 reference
M Mazumdar
1 reference
1 August 2000
1 reference
18
1 reference
2972-2980
1 reference
16
1 reference
Identifiers
1 reference